GTR Home > Tests > Search results - Spinocerebellar ataxia 1

Apply filters

Showing test for 1 condition

reset

Compare labs

Your search term can be found in tests with a total of 1157 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states
More locations

GTR test search results for C0752120[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 61 tests for 1 condition in 44 labs

CSpinocerebellar ataxia type 1

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CAtaxin 1 (ATXN1) gene CAG triplet repeat test

Test targets
Methods
  • T Targeted variant analysis

CSCA1

Lab: Institute for Human Genetics University Clinic Freiburg Freiburg, Baden-Wurttemberg, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CSCA1 DNA Test

Lab: Athena Diagnostics Inc Marlborough, Massachusetts, United States
Test targets
Methods
  • T Targeted variant analysis

CAutosomal Dominant Ataxia Evaluation

Lab: Athena Diagnostics Inc Marlborough, Massachusetts, United States
Test targets
Methods
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (14)
Total targets (14)

CComplete Ataxia Evaluation

Lab: Athena Diagnostics Inc Marlborough, Massachusetts, United States
Test targets
Methods
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (20)
Total targets (20)

CATXN1. CAG expansion detection by PCR

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • T Targeted variant analysis

CSpinocerebellar Ataxia (SCA) Panel

Test targets
Methods
  • T Targeted variant analysis
Total conditions (6)
Total targets (6)

CNuclear-Mito 500 NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (600)
Total targets (500)

CAtaxia (AD/AR) panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (23)
Total targets (16)

CMigraine NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (65)
Total targets (18)

CEpilepsy NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (599)
Total targets (342)

CAmyotrophic Lateral Sclerosis NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (47)
Total targets (24)

Showing 1 to 20 of 61 tests for 1 condition in 44 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Write to the Help Desk